Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Enzastaurin

Enzastaurin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Enzastaurin

31 trials tracked of Enzastaurin: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 20 citations.

31Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 27 Phase 1 2
  1. Phase 3 Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ Completed · 20 cited
  2. Phase 3 PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin Completed
  3. Phase 2 Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas Completed
  4. Phase 2 A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer Completed
  5. Phase 2 Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy Completed
  6. Phase 2 Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer Completed
Show 25 more trials
  1. Phase 2 Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer Completed
  2. Phase 2 Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer Completed
  3. Phase 2 Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients Completed
  4. Phase 2 Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer Completed
  5. Phase 2 A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma Completed
  6. Phase 2 A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only Completed
  7. Phase 2 Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma Completed
  8. Phase 2 Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy Completed
  9. Phase 2 A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer Completed
  10. Phase 2 Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") Completed
  11. Phase 2 Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer Completed
  12. Phase 2 A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients Completed
  13. Phase 2 A Study for Participants With Metastatic Renal Cell Carcinoma Completed
  14. Phase 2 Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy Completed
  15. Phase 2 A Study of Enzastaurin in Participants With Follicular Lymphoma Completed
  16. Phase 2 Chemotherapy for Participants With Lymphoma Completed
  17. Phase 2 A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers Completed
  18. Phase 2 An Open Label Study of Oral Enzastaurin in Participants With Cancer Completed
  19. Phase 2 A Study for Patients With Non-Hodgkin's Lymphomas Completed
  20. Phase 2 First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) Completed
  21. Phase 2 A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma Completed
  22. Phase 2 Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Completed
  23. Phase 2 Enzastaurin for Patients With Metastatic Colorectal Cancer Completed
  24. Phase 1 A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma Completed
  25. Phase 1 A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.